Masimo Corporation $MASI Shares Purchased by UBS Group AG

Key Points

• UBS boosted its position in Masimo by 252.9% in Q4, adding 429,474 shares to hold 599,274 shares (about 1.12% of the company) valued at roughly $77.94 million.
• Wall Street is broadly cautious: eight analysts rate MASI as Hold and one as Sell, giving a consensus rating of "Reduce" and a target price of $181.17; the stock trades near $178 with a market cap of $9.59 billion and a negative trailing PE of -16.93.

UBS Group AG boosted its position in Masimo Corporation (NASDAQ:MASI - Free Report) by 252.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 599,274 shares of the medical equipment provider's stock after acquiring an additional 429,474 shares during the quarter. UBS Group AG owned 1.12% of Masimo worth $77,942,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in the company. Royal Bank of Canada increased its position in shares of Masimo by 44.5% in the 1st quarter. Royal Bank of Canada now owns 43,884 shares of the medical equipment provider's stock valued at $7,311,000 after purchasing an additional 13,513 shares during the last quarter. AQR Capital Management LLC lifted its position in shares of Masimo by 136.5% during the 1st quarter. AQR Capital Management LLC now owns 8,142 shares of the medical equipment provider's stock worth $1,305,000 after purchasing an additional 4,700 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Masimo by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider's stock worth $1,894,000 after purchasing an additional 66 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in shares of Masimo during the first quarter worth $220,000. Finally, Jones Financial Companies Lllp increased its holdings in Masimo by 1,267.1% in the first quarter. Jones Financial Companies Lllp now owns 2,201 shares of the medical equipment provider's stock valued at $367,000 after buying an additional 2,040 shares during the last quarter. Hedge funds and other institutional investors own 85.96% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on MASI. Piper Sandler downgraded Masimo from an "overweight" rating to a "hold" rating and set a $180.00 price target for the company. in a report on Tuesday, February 17th. Stifel Nicolaus set a $180.00 price objective on Masimo in a report on Tuesday, February 17th. BTIG Research cut Masimo from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 18th. Wells Fargo & Company raised Masimo to a "hold" rating in a report on Wednesday, March 18th. Finally, Weiss Ratings reiterated a "sell (d)" rating on shares of Masimo in a research note on Thursday, January 22nd. Eight investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Reduce" and a consensus target price of $181.17.

Masimo Stock Performance

NASDAQ MASI opened at $178.48 on Monday. The company has a fifty day moving average of $177.21 and a two-hundred day moving average of $153.98. The company has a market capitalization of $9.59 billion, a PE ratio of -16.93, a P/E/G ratio of 1.81 and a beta of 1.13. Masimo Corporation has a 1 year low of $125.94 and a 1 year high of $179.00. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.49 and a quick ratio of 1.47.

About Masimo

Masimo NASDAQ: MASI is a global medical technology company specializing in noninvasive monitoring solutions. The company's flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo's portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.